New copycat arthritis drug tested in healthy men
NCT ID NCT06392074
Summary
This study tested a new, potentially cheaper version (MB04) of the arthritis drug Enbrel. It involved 141 healthy male volunteers who received single doses of the new drug and the original versions. Researchers compared how the drugs moved through the body and checked for safety to see if they were similar.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Clinical Research Unit
Groningen, Provincie Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.